C. Purpose of this Guidance, Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA
- To outline the practical arrangements for notification.
- To provide advice on what should and what should not be classified as a “serious breach” and what must be reported.
- To outline possible actions that may be taken by the MHRA in response to notifications of serious breaches.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Aankomende klinische onderzoeken
-
Fondazione Policlinico Universitario Agostino Gemelli...Nog niet aan het werven
-
National Taiwan University HospitalNational Taiwan University Hospital Bei-Hu BranchWerving
-
University of British ColumbiaMcMaster UniversityNog niet aan het werven
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...WervingDe klinische werkzaamheid en veiligheid van Finerenone bij de behandeling van primair aldosteronismePrimair aldosteronisme | Mineralocorticoïde receptorantagonist | FinerenonChina
-
Zoya Haitov Ben ZikriWervingVerstandskiezen trekken of kaakimplantaatIsraël
-
Cairo UniversityWerving
-
AstraZenecaMerck Sharp & Dohme LLCWervingGemetastaseerde castratieresistente prostaatkankerDuitsland
-
University Hospital, MotolNog niet aan het wervenDiabetes mellitus type 1 | Diabetes mellitus type 1 met hypoglykemie | Rit
-
University of LouisvilleNog niet aan het wervenMyocardiaal letselVerenigde Staten
-
University of MiamiWerving
-
University of ConnecticutYale UniversityNog niet aan het werven
-
Pamukkale UniversityNog niet aan het wervenPremenstrueel syndroom | Gelach